© Reuters. J&J Earnings, Revenue Beat in Q1
Investing.com – J&J reported on Tuesday first quarter that beat analysts’ forecasts and revenue that topped expectations.
J&J announced earnings per share of $2.59 on revenue of $22.32B. Analysts polled by Investing.com anticipated EPS of $2.33 on revenue of $22.01B.
J&J shares are up 3% from the beginning of the year, still down 6.28% from its 52 week high of $173.59 set on January 26. They are under-performing the Dow Jones which is up 11.34% from the start of the year.
J&J follows other major Healthcare sector earnings this month
J&J’s report follows an earnings beat by Signify Health on March 24, who reported EPS of $0.06 on revenue of $193.5M, compared to forecasts EPS of $0.0535 on revenue of $188.94M.
Neogen had missed expectations on March 23 with third quarter EPS of $0.25 on revenue of $116.71M, compared to forecast for EPS of $0.2567 on revenue of $106.73M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.